7 results
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI) - Non-Opioid ... Management #Pain #Pharmacology ... #NonOpioid #Analgesics ... #Medications #Doses ... #Dosing #Table
Alternatives to opioids for pain management in the emergency department decreases opioid usage and maintains patient
usage and maintains ... #Management #Pharmacology ... #NonOpioid #Alternatives ... PainSyndromes #Indications ... #Pathways #Table
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
in which higher doses ... margin of safety in pharmacology ... the sublingual tablet ... #Comparison #Table ... #Pharmacology #
Taken from Dr Motov's work on a CERTA regime.
This is published in conjunction with the CERTA
other than just opioid ... medications. ... #Management #Pharmacology ... #NonOpioid #Opiate ... PainSyndromes #Pathways #Table
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... insulin by ~20% • Never ... Adjust insulin dose ... #pharmacology # ... comparison #table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... drug to remain stable ... take any other medications ... patients to take meds ... semaglutide #Diabetes #Pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Does the patient ... or family - Ever ... - Allergies to medications ... event, follow ACC algorithm ... Cataract Plan for Meds